These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 18081729)
1. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease. Thoua NM; Khoo D; Kalantzis C; Emmanuel AV Aliment Pharmacol Ther; 2008 Mar; 27(5):396-403. PubMed ID: 18081729 [TBL] [Abstract][Full Text] [Related]
2. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups. Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Frazzoni M; De Micheli E; Zentilin P; Savarino V Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174 [TBL] [Abstract][Full Text] [Related]
4. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Caviglia R; Ribolsi M; Gentile M; Rabitti C; Emerenziani S; Guarino MP; Petitti T; Cicala M Aliment Pharmacol Ther; 2007 Mar; 25(5):629-36. PubMed ID: 17305764 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Frazzoni M; Manno M; De Micheli E; Savarino V Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016 [TBL] [Abstract][Full Text] [Related]
6. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial. Bautista J; Fullerton H; Briseno M; Cui H; Fass R Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202 [TBL] [Abstract][Full Text] [Related]
7. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease. Emerenziani S; Ribolsi M; Sifrim D; Blondeau K; Cicala M Neurogastroenterol Motil; 2009 Mar; 21(3):253-8. PubMed ID: 19019016 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease. Wada T; Sasaki M; Kataoka H; Tanida S; Itoh K; Ogasawara N; Oshima T; Togawa S; Kubota E; Yamada T; Mori Y; Fujita F; Ohara H; Nakao H; Sobue S; Joh T; Itoh M Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():2-9. PubMed ID: 15943840 [TBL] [Abstract][Full Text] [Related]
9. Differences in oesophageal bolus transit between patients with and without erosive reflux disease. Chen CL; Yi CH; Cook IJ Dig Liver Dis; 2008 May; 40(5):348-54. PubMed ID: 18291736 [TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis. Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268 [TBL] [Abstract][Full Text] [Related]
11. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Miwa H; Minoo T; Hojo M; Yaginuma R; Nagahara A; Kawabe M; Ohkawa A; Asaoka D; Kurosawa A; Ohkusa T; Sato N Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():112-7. PubMed ID: 15298616 [TBL] [Abstract][Full Text] [Related]
12. Does this patient have oesophageal motility abnormality or pathological acid reflux? Hong SN; Rhee PL; Kim JH; Lee JH; Kim YH; Kim JJ; Rhee JC Dig Liver Dis; 2005 Jul; 37(7):475-84. PubMed ID: 15975533 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Dickman R; Parthasarathy S; Malagon IB; Jones P; Han B; Powers J; Fass R Aliment Pharmacol Ther; 2007 Jul; 26(1):41-8. PubMed ID: 17555420 [TBL] [Abstract][Full Text] [Related]
16. Relief of reflux symptoms after endoscopic gastroplication may be associated with reduced esophageal Acid sensitivity: a pilot study. Wenzel G; Kuhlbusch R; Heise J; Frieling T Endoscopy; 2005 Mar; 37(3):236-9. PubMed ID: 15731939 [TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis. Weijenborg PW; Smout AJ; Verseijden C; van Veen HA; Verheij J; de Jonge WJ; Bredenoord AJ Am J Physiol Gastrointest Liver Physiol; 2014 Aug; 307(3):G323-9. PubMed ID: 24924748 [TBL] [Abstract][Full Text] [Related]
18. Overweight is a risk factor for both erosive and non-erosive reflux disease. Savarino E; Zentilin P; Marabotto E; Bonfanti D; Inferrera S; Assandri L; Sammito G; Gemignani L; Furnari M; Dulbecco P; Savarino V Dig Liver Dis; 2011 Dec; 43(12):940-5. PubMed ID: 21944835 [TBL] [Abstract][Full Text] [Related]
20. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]